Jim Simons Aim Immuno Tech Inc. Transaction History

Renaissance Technologies LLC

$63.6 Billion
Q1 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Aim Immuno Tech Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 220,808 shares of AIM stock, worth $88,323. This represents 0.0% of its overall portfolio holdings.

Number of Shares

220,808

Previous 202,008 9.31%

Holding current value

$88,323

Previous $89,000 16.85%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$0.33 - $0.48 $6,204 - $9,024	18,800 Added 9.31%	220,808 $104,000
Q4 2023 Feb 13, 2024	BUY	$0.4 - $0.56 $3,880 - $5,432	9,700 Added 5.04%	202,008 $89,000
Q3 2023 Nov 14, 2023	BUY	$0.44 - $0.71 $5,940 - $9,585	13,500 Added 7.55%	192,308 $88,000
Q2 2023 Aug 11, 2023	BUY	$0.4 - $0.67 $4,040 - $6,767	10,100 Added 5.99%	178,808 $120,000
Q1 2023 May 12, 2023	BUY	$0.32 - $0.77 $10,176 - $24,486	31,800 Added 23.23%	168,708 $73,000

Q4 2022 Feb 13, 2023	BUY	$0.31 - $0.6 $3,720 - $7,200	12,000 Added 9.61%	136,908 $43,000
Q3 2022 Nov 14, 2022	BUY	$0.57 - $0.81 $2,565 - $3,645	4,500 Added 3.74%	124,908 $73,000
Q2 2022 Aug 12, 2022	SELL	$0.78 - $1.27 $239,977 - $390,732	-307,663 Reduced 71.87%	120,408 $94,000
Q1 2022 May 13, 2022	SELL	$0.67 - $1.18 $185,609 - $326,894	-277,029 Reduced 39.29%	428,071 $454,000
Q4 2021 Feb 11, 2022	BUY	$0.92 - $1.96 $648,692 - $1.38 Million	705,100 New	705,100 $649,000
Q3 2021 Nov 12, 2021	SELL	$1.91 - $2.17 $291,939 - $331,680	-152,848 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$1.93 - $2.39 $629,008 - $778,927	-325,911 Reduced 68.07%	152,848 $329,000
Q1 2021 May 13, 2021	BUY	$1.88 - $2.82 $900,066 - $1.35 Million	478,759 New	478,759 $1.09 Million
Q1 2020 May 14, 2020	SELL	$0.56 - $6.1 $9,688 - $105,530	-17,300 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$0.39 - $0.71 $6,747 - $12,283	17,300 New	17,300 $9,000

Others Institutions Holding AIM

# of Institutions

Shares Held

4.11M

Call Options Held

Put Options Held

View Full List

About AIM ImmunoTech Inc.

Ticker AIM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,049,300
Market Cap $19.2M
Description
AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome...

More about AIM

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account